Skip to main content
Caplight Logo









Endurance Bio Inc.

Endurance Bio Inc.

Private
Cupertino, CaliforniaHealthcare & Life Scienceshttps://www.endurance-bio.com/

Last Round

VC Round

Dec 31, 2025

Company Overview

Endurance Bio Inc. is a biotechnology company that develops orally bioavailable small molecule therapeutics to restore mitochondrial and lysosomal health for the treatment of neurodegenerative and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small molecule therapeuticsbiotechnologydrug discoveryneurodegenerative diseasemetabolic diseaseclinical-stage biotechmitochondrial healthlysosomal functiondrug pipelineclinical trialsbiotech startuppharma licensingdrug developmentaging researchtherapeutic candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Endurance Bio Inc. Comparables

Compare Endurance Bio Inc. with similar companies based on industry and business-model similarity.

Endurance Bio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arkuda Therapeutics
81%
Capacity Bio
81%
Vandria
80%

Endurance Bio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 31, 2025
AngelApr 30, 2025

Endurance Bio Inc. Investors

Notable investors and investment history

Endurance Bio Inc. investors
InvestorRounds
Remiges VenturesVC Round

Endurance Bio Inc. Filings

Explore SEC and related filing metadata, where available.

Endurance Bio Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Endurance Bio Inc.'s valuation, stock price, and market status.

Is Endurance Bio Inc. a public or private company?

Endurance Bio Inc. is a private company.

What is the current stock price of Endurance Bio Inc.?

Endurance Bio Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Endurance Bio Inc. worth (valuation)?

Valuation information for Endurance Bio Inc. is not publicly available.

Can I buy Endurance Bio Inc. stock?

Endurance Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Endurance Bio Inc.'s last funding round?

Endurance Bio Inc.'s most recent funding round was VC Round on December 31, 2025.

Who are the main investors in Endurance Bio Inc.?

Key investors in Endurance Bio Inc. include Remiges Ventures.

Will Endurance Bio Inc. IPO soon?

No public IPO plans have been announced for Endurance Bio Inc..

How can I track Endurance Bio Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Endurance Bio Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCupertino, California
Year Founded2025
Last FundingDec 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?